Associations between depressive symptoms and inflammatory/hemostatic markers in women during the menopausal transition

Psychosomatic Medicine

Volumn 69, Issue 2, 2007, Pages 124-130

  Matthews, Karen A ^a,b   Schott, Laura L ^b   Bromberger, Joyce ^a,b   Cyranowski, Jill ^a   Everson Rose, Susan A ^c   Sowers, Mary Fran ^d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c RUSH UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Depression; Hemostatis; Inflammation; Longitudinal; Menopause; Women

Indexed keywords

BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7 C; C REACTIVE PROTEIN; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ADULT; AFRICAN AMERICAN; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CAUCASIAN; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CHINESE; CLIMACTERIUM; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC ACCURACY; DISEASE MARKER; ETHNICITY; FEMALE; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HEMOSTASIS; HISPANIC; HUMAN; HYPERCOAGULABILITY; JAPANESE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SAMPLE SIZE; SYMPTOM; BLOOD; CARDIOVASCULAR DISEASE; IMMUNOLOGY; INFLAMMATION; MIDDLE AGED; PSYCHOLOGICAL ASPECT; RISK FACTOR;

ADULT; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; DEPRESSION; FEMALE; HUMANS; INFLAMMATION; LONGITUDINAL STUDIES; MENOPAUSE; MIDDLE AGED; RISK FACTORS;

EID: 33847717881     PISSN: 00333174     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.psy.0000256574.30389.1b     Document Type: Article

References (31)

1. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999;99:2192-217.
2. Suls J, Bunde J. Anger, anxiety, and depression as risk factors for cardiovascular disease: the problems and implications of overlapping affective dispositions. Psych Bull 2005;131:260-300.
3. Gallo LC, Matthews KA. Understanding the association between socioeconomic status and physical health: do negative emotions play a role? Psych Bull 2003;129:10-51.
4. Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res 2002;53:897-902.
5. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-26.
6. Lee KW, Lip GYH. Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity. Arch Intern Med 2003;163:2368-93.
7. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006;27:24-31.
8. Joynt KE, Whellan DJ, O'Conner CM. Depression and cardiovascular disease: mechanisms on interaction. Biol Psychiatry 2003;54:248-61.
9. Kop WJ, Gottdiener JS, Tangen CM, Fried LP, McBurnie MA, Walston J, Newman A, Hirsch C, Tracy RP. Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol 2002;89:419-24.
10. Tiemeier H, Hofman A, van Tuijl HR, Kiliaan AJ, Meijer J, Breteler MMB. Inflammatory proteins and depression in the elderly. Epidemiology 2003;14:103-7.
11. Penninx BWJH, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S, Ferrucci L, Harris T, Pahor M. Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study. Biol Psychiatry 2003;54:566-72.
12. Steptoe A, Kunz-Ebrecht SR, Owen N. Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women. Psychol Med 2003;33:667-74.
13. Ford DE, Erlinger TP. Depression and c-reactive protein in US adults: data from the third national health and nutrition examination survey. Arch Intern Med 2004;164:1010-4.
14. Danner M, Kasl SV, Abramson JL, Vaccarino V. Association between depression and elevated c-reactive protein. Psychosom Med 2003;65:347-56.
15. Panagiotakos DB, Pitsavos C, Chrysohoou C, Tsetsekou E, Papageorgiou C, Christodoulou G, Stefanadis C. Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. Eur Heart J 2004;25:492-9.
16. Miller GE, Freedland KE, Carney RM, Stetler CA, Banks WA. Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immunity 2003;17:276-85.
17. Ladwig KH, Marten-Mittag B, Löwel H, Döring A, Koenig W. Influence of depressive mood on the association of CRP and obesity in 3205 middle aged healthy men. Brain Behav Immunity 2003;17:268-75.
18. Douglas KM, Taylor AJ, O'Malley PG. Relationship between depression and C-reactive protein in a screening population. Psychosom Med 2004;66:679-83.
19. Sowers MF, Crawford S, Sternfeld B, Morganstein D, Gold E, Greendale G, Evans D, Neer R, Matthews KA, Sherman S, Lo A, Weiss G, Kelsey J. SWAN: a multi- center, multi- ethnic community-based cohort study of women and the menopausal transition. In: Lobo R, Marcus R, Kelsey J, editors. Menopause: Biology and Pathology. New York: Academic Press; 2000.
20. Radloff R, Versons S. The CES-D Scale: a self-report symptom scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
21. Guarnacca PJ, Angel R, Worobey JL. The factor structure of the CES-D in the Hispanic health and nutrition examination survey: the influences of ethnicity, gender and language. Soc Sci Med 1989;29:85-94.
22. Roberts RE. Reliability of the CES-D scale in different ethnic contexts. Psychiatry Res 1980;2:125-34.
23. Ying YW. Depressive symptomatology among Chinese-Americans as measured by the CES-D. J Clin Psychol 1988;44:739-46.
24. Sternfeld B, Ainsworth BE, Quesenberry CP Jr. Physical activity patterns in a diverse population of women. Prev Med 1999;28:313-23.
25. Yerbeke G, Molenberghs G. Linear mixed models for longitudinal data. New York: Springer; 2000.
26. Matthews KA, Sowers MF, Derby C, Stein E, Miracle-McMahill H, Crawford S. Ethnic differences in cardiovascular risk factor burden among middle-aged women: study of women's health across the nation (SWAN). Am Heart J 2005;149:1066-73.
27. Sowers MR, Jannausch M, Randolph JF, McConnenell D, Little R, Lasley B, Pasternak R, Sutton-Tyrrell K, Matthews KA. Androgens are associated with hemostatic and inflammatory factors among women at mid-life. J Clin Endocrinol Metab 2005;90:6064-71.
28. Sowers MR, Matthews KA, Kannuausch M, Randolph JF, McConnell D, Sutton-Tyrrell K, Little R, Lasley B, Pasternak R. Hemostatic factors and estrogen during the menopausal transition. J Clin Endocrinol Metab 2005;90:5943-8.
29. Cushman M. Effects of hormone replacement therapy and estrogen receptor modulators on markers of inflammation and coagulation. Am J Cardiol 2002;90:7F-10F.
30. Colditz GA, Willet WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Eng J Med 1987;316:1105-10.
31. Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Are users of estrogen replacement therapy healthier prior to use than nonusers. Am J Epidemiol 1996;143:971-8.